OTC Loperamide Cardiovascular Label Warnings In US Spread To Perrigo Products
Executive Summary
FDA approval for Perrigo's ANDA for two loperamide products listed as tablets follows CBE label changes Johnson & Johnson and BionPharma made for their branded OTCs containing the ingredient in 2019.